Summary
The confidence interval approach to bioavailability assessment depends first on selection of the confidence level, usually 95%, and then determination of the confidence limits for the expected bioavailability ratio AUC(Test)/AUC(Reference). In practice, however, it is sometimes of greater interest to know the probability that the expected bioavailability will fall below a critical value, for example 0.75, or within a clinically set bioequivalence range, for example 0.80 to 1.25. Up to now, posterior probability distributions have been suggested, based on classical analysis of variance (ANOVA) with its rather restrictive assumptions, including that of a (logarithmic) normal distribution. In this report, a distribution-free confidence interval based on the Wilcox-on signed-rank statistic has been generalized so that confidence probabilities can be obtained for any given confidence limits. In the case of unimodal and almost symmetrical sampling distributions, the results obtained are very similar to those of the ANOVA-based posterior probability distribution. However, skewed or multimodal sampling distributions are better reflected by the proposed distribution-free method, and more valid information is obtained in these cases, as demonstrated by examples.
Similar content being viewed by others
References
Fluehler H, Hirtz J, Moser HA (1981) An aid to decision-making in bioequivalence assessment. J Pharmacokinet Biopharm 9: 235–243
Fluehler H, Grieve AP, Mandallaz D, Mau J, Moser HA (1983) Bayesian approach to bioequivalence assessment; an example. J Pharm Sci 72: 1178–1181
Hollander M, Wolfe DA (1973) Nonparametric statistical methods. Wiley, New York, pp 35–38
Kramer WG, Kolibash AJ, Bathala MS, Visconti JA, Lewis RP, Reuning RH (1977) Digoxin bioavailability: Evaluation of a generic tablet and proposed FDA guidelines. J Pharm Sci 66: 1720–1722
Mandallaz D, Mau J (1981) Comparison of different methods for decision-making in bioequivalence assessment. Biometrics 37: 213–222
Steinijans VW, Diletti E (1983) Statistical analysis of bioavailability studies: Parametric and nonparametric confidence intervals. Eur J Clin Pharmacol 24: 127–136
Wijnand HP, Timmer CJ (1983) Mini-computer programs for bioequivalence testing of pharmaceutical drug formulations in two-way cross-over studies including a survey of current parametric evaluation techniques. Computer Programs Biomed 17: 73–88
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Steinijans, V.W., Diletti, E. Generalization of distribution – Free confidence intervals for bioavailability ratios. Eur J Clin Pharmacol 28, 85–88 (1985). https://doi.org/10.1007/BF00635713
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00635713